The global demand for Trichomonas Rapid Testing Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Trichomonas rapid testing is a diagnostic procedure used to detect trichomoniasis, a sexually transmitted infection (STI) often spread through vaginal, oral, or anal sex. The testing method uses color immunochromatographic “dipstick” technology. The test procedure involves mixing the vaginal swab in a sample buffer, leading to trichomonas proteins’ solubilization. Test results are available within 10 minutes. Freezing or transportation of specimens will not alter the test results. This testing method can effectively treat the most common curable STI in young, sexually active men and women. If left undetected, trichomoniasis can increase the risk of getting HIV/AIDS and cause complications during pregnancy.
Trichomoniasis being the most prevalent nonviral sexually transmitted infection worldwide will be the primary motivating factor for this market’s growth. Trichomonas’ rapid testing can reduce the rate of inaccurate treatment of uninfected adolescents and lead to better antibiotic stewardship. This market will witness a surge soon since this diagnostic method is relatively cheap with lesser turnaround time. The demand for testing is on the rise among pregnant women since undetected cases can lead to HIV or complicated pregnancy. This market’s main challenges are lack of awareness and the high percentage of asymptomatic patients besides the infection’s high prevalence rate.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of trichomonas rapid testing.
The entire trichomonas rapid testing market has been sub-categorized into product type and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product Type
By End User
- Wet Mount Trichomonas Rapid Diagnostic Test Kit
- PCR based Trichomonas Rapid Diagnostic Test Kit
- Xenostrip Tests
- Diagnostic Laboratories
- Speciality Clinics
This section covers regional segmentation which accentuates on current and future demand for trichomonas rapid testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Trichomonas Rapid Testing Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the trichomonas rapid testing market include Quidel Corporation, McKesson Medical-Surgical Inc., Sekisui Diagnostics, Genzyme Diagnostics, Nanjing Liming Bio-Products Co., Ltd., Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.